Global Nanomedicine Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026

Published Date : Aug 2019 | No. of Pages : 140 Pages | Category : Healthcare

The global nanomedicine market size is anticipated to reach arond USD 352.7 billion by 2026.

The report provides size (in terms of volume and value) of nanomedicine market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

Nanomedicine is one of the applications of nanotechnology used in diagnosis, treatment, monitoring, and control of biological systems. Nanomedicine uses nanoscale manipulation of materials to improve medicine delivery. Thus, nanomedicine has facilitated the treatment against various diseases. Nanomedicine is in nascent stage, as several products are in the development phase. According to Nanobiotix (a nanomedicine company), in 2015, around 230 nanomedicine products were identified, which are either marked or are in the trial phase. Moreover, as per the company, there are 49 nanomedicine products in the market, whereas 122 products are in the clinical pipeline either in Phase II or Phase III trials.

Drivers, Restraints, and Opportunities

The global nanomedicine market is driven by emerging technologies for drug delivery, increase in adoption of nanomedicine across varied applications, rise in government support & funding, growth in need for therapies with fewer side effects, and cost-effectiveness of therapies. However, long approval process and risks associated with nanomedicine (environmental impacts) restrain the market growth. In addition, increase in out-licensing of nanodrugs and growth of healthcare facilities in emerging economies are anticipated to provide numerous opportunities for the growth of nanomedicine market.

The key players operating in the global nanomedicine market are Abbott Laboratories, CombiMatrix Corporation, General Electric Company, Sigma-Tau Pharmaceuticals, Inc., Johnson & Johnson, Mallinckrodt plc., Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., and Teva Pharmaceutical Industries Ltd.

The other prominent players in the value chain include Celgene Corporation, UCB (Union Chimique Belge) S.A., AMAG Pharmaceuticals, Nanospectra Biosciences, Inc., Arrowhead Pharmaceuticals, Inc., Leadiant Biosciences, Inc., Epeius Biotechnologies Corporation Gilead, and Cytimmune Sciences, Inc.

Further key findings from the report suggest:

  • Therapeutics accounted for the largest share of market revenue in 2016 owing to presence of nanoemulsions, nanoformulations, or nanodevices
  • These devices possess the ability to cross biological barriers. Moreover, presence of drugs such as Doxil, Abraxane, and Emend is attributive for higher revenue generation
  • Presence of substantial number of products manufactured through the use of microbial sources can be attributed for the largest share
  • In-vitro diagnostics is expected to witness lucrative progress as a result of R&D carried out in this segment
  • Introduction of nano-enabled biomarkers, vectors and contrast agents with high-specificity and sensitivity are attributive for projected progress
  • Clinical cardiology is expected to witness the fastest growth through to 2025 owing to development in nano-functionalization and modification of surfaces for increased biocompatibility of implants in treatment of late thrombosis
  • Moreover, an abundance of research publications and patent filings from European region with a share of about 25% in nanomedicine-related publications is supportive for revenue generation from European economies
  • Asia Pacific is estimated to witness the fastest growth over the forecast period
  • Factors responsible include government and regulatory authorities that have implemented a framework to encourage R&D collaborations and framework extension.
  • Key players operating in this industry include Pfizer Inc., Ablynx NV, Nanotherapeutics Inc., Nanoviricides Inc., Abraxis Inc., Arrowhead Research Inc., Celgene Corporation, Bio-Gate AG, and Merck
  • Active expansion strategies are undertaken by a number of the major market entities in order to strengthen their position
  • North America dominated the industry in 2016, accounting for a 42% of total revenue
  • Presence of key participants operating in the region are involved in collaborative activities are attributive for the largest share of North America in sector revenue

Segmentation:

Nanomedicine Product Outlook

  • Therapeutics

  • Regenerative medicine

  • In-vitro diagnostics

  • In-vivo diagnostics

  • Vaccines

Nanomedicine Application Outlook

  • Clinical Oncology

  • Infectious diseases

  • Clinical Cardiology

  • Orthopedics

  • Others

Nanomedicine Nanomolecule Type Outlook

  • Nanoparticles

    • Metal & Metal Oxide Nanoparticles

      • By Type

        • Gold Nanoparticles

        • Silver Nanoparticles

        • Iron Oxide Nanoparticles

        • Alumina Nanoparticles

        • Gadolinium Oxide Nanoparticles

        • Others

      • By Application

        • In-vivo Imaging

        • Targeted Drug Delivery

        • Proton Therapy

        • In-vitro assays

        • Cell & Phantom Imaging

    • Liposomes

    • Polymers & polymer drug conjugates

    • Hydrogel nanoparticles

    • Dendrimers

    • Inorganic nanoparticles

  • Nanoshells

  • Nanotubes

  • Nanodevices

Nanomedicine Regional Outlook

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • UK

  • Asia Pacific

    • Japan

    • China

  • Latin America

    • Brazil

  • Middle East and Africa (MEA)

    • South Africa

 


Featured Research Reports

  • Featured Research Reports

    U.S. Virtual Visits Market (By Service Type: Cold & Flu management, Allergies, Urgent Care, Preventive Care, Chronic Care Management, Behavioural Health ; By Commercial Plan Type: Small Group, Self-Funded/ASO Group Plans, Medicaid, Medicare, By Age Group, By Gender)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Next-Generation Sequencing Services Market (By Service Type: Human Genome Sequencing, Gene Regulation Services; By Workflow: Pre-sequencing, Sequencing, Data Analysis; By End-use)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Pediatric Clinical Trials Market (By Phase: Phase II, IV; By Study Design: Treatment, Observational Studies; By Therapeutic Areas: Mental Health Disorders, Oncology)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    Medical Digital Imaging Systems Market (By Type: X-ray, MRI, Ultrasound, CT, Nuclear Imaging; By Technology: 2D, 3D/4D) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...
  • Featured Research Reports

    U.S. Pharmacy Benefit Management Market (By Business Model: Standalone, Health Insurance Providers, Retail Pharmacy; By End Use: Commercial, Federal) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

    Read more...